White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin

Abstract

To the best of our knowledge, this is the first DTI study to investigate the effects of EPO in a neurodegenerative disease. Anatomically, the diffusivity changes appear disease unspecific, and their biological underpinnings deserve further study.